IRME
IR-Med Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.05 |
| Day High | $0.05 |
| Day Low | $0.05 |
| Volume | 594 |
Stock Information
| Shares Outstanding | 110.06M |
| Total Debt | $250K |
| Cash Equivalents | $63K |
| Net Income | $-2.35M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $770K |
| EPS (TTM) | $-0.04 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $728K |
| Income | $-2.35M |
| Book/sh | $-0.01 |
| Cash/sh | $0.00 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 0.12 |
| Current Ratio | 0.12 |
Returns & Margins
| ROA | -172.32% |
Ownership
| Insider Ownership | 44.36% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.70 |
| P/B | -0.88 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.02 |
| RSI | nan |
| Shares Float | 44.07M |
| Volatility | 0.62 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +600.00% |
| 6 Months | -82.50% |
| YTD | -82.50% |
| Year | -91.25% |
| 3 Years | -98.73% |
| 5 Years | -99.77% |
| 10 Years | -99.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.01 | 0 |
| 2026-06-23 | $0.01 | 0 |
| 2026-06-22 | $0.01 | 0 |
| 2026-06-18 | $0.01 | 0 |
| 2026-06-17 | $0.01 | 0 |
| 2026-06-16 | $0.01 | 0 |
| 2026-06-15 | $0.01 | 0 |
| 2026-06-12 | $0.01 | 0 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 0 |
| 2026-06-08 | $0.01 | 0 |
| 2026-06-05 | $0.01 | 0 |
| 2026-06-04 | $0.01 | 0 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 0 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 0 |
About IR-Med Inc.
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
đ° Latest News
No news articles available at the moment. Check back later for updates on IRME.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $1,941,000 | $4,911,000 | $4,762,000 | $3,675,000 |
| Rent Expense Supplemental | $115,000 | $94,000 | $84,000 | $51,000 |
| Other Income Expense | $46,000 | $-17,000 | $35,000 | $-35,000 |
| Other Non Operating Income Expenses | $48,000 | - | - | - |
| Net Non Operating Interest Income Expense | $-4,000 | $19,000 | $-7,000 | $-6,000 |
| Total Other Finance Cost | $4,000 | $-19,000 | $1,000 | $1,000 |
| Operating Expense | $1,941,000 | $4,911,000 | $4,762,000 | $3,675,000 |
| Other Operating Expenses | $-410,000 | $127,000 | $125,000 | $69,000 |
| Selling And Marketing Expense | $0 | $10,000 | $21,000 | $888,000 |
| General And Administrative Expense | $1,152,000 | $2,696,000 | $2,721,000 | $1,294,000 |
| Interest Expense | - | - | $6,000 | $5,000 |
| Interest Expense Non Operating | - | - | $6,000 | $5,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Net Interest Income | $-4,000 | $19,000 | $-7,000 | $-6,000 |
| Normalized Income | $-1,897,000 | $-4,892,000 | $-4,769,000 | $-3,681,000 |
| Net Income From Continuing And Discontinued Operation | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Total Operating Income As Reported | $-1,941,000 | $-4,911,000 | $-4,762,000 | $-3,675,000 |
| Net Income Common Stockholders | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Net Income | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Net Income Including Noncontrolling Interests | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Net Income Continuous Operations | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Pretax Income | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Operating Income | $-1,941,000 | $-4,911,000 | $-4,762,000 | $-3,675,000 |
| Depreciation Amortization Depletion Income Statement | $21,000 | $17,000 | $10,000 | $5,000 |
| Depreciation And Amortization In Income Statement | $21,000 | $17,000 | $10,000 | $5,000 |
| Depreciation Income Statement | $21,000 | $17,000 | $10,000 | $5,000 |
| Interest Income | - | $20,000 | - | - |
| Interest Income Non Operating | - | $20,000 | - | - |
| Per Share | ||||
| Diluted EPS | $-0.03 | $-0.07 | $-0.07 | $-0.06 |
| Basic EPS | $-0.03 | $-0.07 | $-0.07 | $-0.06 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,918,000 | $-4,877,000 | $-4,753,000 | $-3,671,000 |
| Total Unusual Items | $-2,000 | $-17,000 | $35,000 | $-35,000 |
| Total Unusual Items Excluding Goodwill | $-2,000 | $-17,000 | $35,000 | $-35,000 |
| Reconciled Depreciation | $21,000 | $17,000 | $10,000 | $5,000 |
| EBITDA (Bullshit earnings) | $-1,920,000 | $-4,894,000 | $-4,718,000 | $-3,706,000 |
| EBIT | $-1,941,000 | $-4,911,000 | $-4,728,000 | $-3,711,000 |
| Diluted Average Shares | $70,474,262 | $69,404,351 | $67,577,734 | $63,110,764 |
| Basic Average Shares | $70,474,262 | $69,404,351 | $67,577,734 | $63,110,764 |
| Diluted NI Availto Com Stockholders | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Gain On Sale Of Security | $-2,000 | $-17,000 | $35,000 | $-35,000 |
| Research And Development | $1,178,000 | $2,061,000 | $1,885,000 | $1,419,000 |
| Selling General And Administration | $1,152,000 | $2,706,000 | $2,742,000 | $2,182,000 |
| Other Gand A | $506,000 | $836,000 | $970,000 | $341,000 |
| Rent And Landing Fees | $115,000 | $94,000 | $84,000 | $51,000 |
| Salaries And Wages | $531,000 | $1,766,000 | $1,667,000 | $902,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-294,000 | $365,000 | $2,592,000 | $2,371,000 |
| Total Assets | $251,000 | $999,000 | $3,294,000 | $2,943,000 |
| Total Non Current Assets | $46,000 | $151,000 | $237,000 | $61,000 |
| Other Non Current Assets | $11,000 | $11,000 | $11,000 | $30,000 |
| Current Assets | $205,000 | $848,000 | $3,057,000 | $2,882,000 |
| Prepaid Assets | $22,000 | $30,000 | $12,000 | $1,000 |
| Receivables | $54,000 | $51,000 | $43,000 | $66,000 |
| Other Receivables | $51,000 | $40,000 | $40,000 | $63,000 |
| Cash Cash Equivalents And Short Term Investments | $129,000 | $767,000 | $3,002,000 | $2,815,000 |
| Cash And Cash Equivalents | $129,000 | $767,000 | $3,002,000 | $2,815,000 |
| Cash Financial | $129,000 | $767,000 | $3,002,000 | $2,815,000 |
| Non Current Prepaid Assets | - | - | - | $30,000 |
| Debt | ||||
| Net Debt | $28,000 | - | - | - |
| Total Debt | $157,000 | $200,000 | $276,000 | $177,000 |
| Current Debt And Capital Lease Obligation | $157,000 | $39,000 | $236,000 | - |
| Current Debt | $157,000 | - | $162,000 | - |
| Other Current Borrowings | $157,000 | - | $162,000 | - |
| Long Term Debt And Capital Lease Obligation | - | $161,000 | $40,000 | $177,000 |
| Long Term Debt | - | $161,000 | - | $177,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $545,000 | $634,000 | $702,000 | $572,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $161,000 | $40,000 | $177,000 |
| Current Liabilities | $545,000 | $473,000 | $662,000 | $395,000 |
| Current Deferred Liabilities | $0 | $50,000 | $50,000 | $0 |
| Payables And Accrued Expenses | $388,000 | $384,000 | $376,000 | $395,000 |
| Payables | $172,000 | $126,000 | $151,000 | $126,000 |
| Accounts Payable | $58,000 | $62,000 | $65,000 | $58,000 |
| Other Payable | - | - | $3,000 | $3,000 |
| Equity | ||||
| Common Stock Equity | $-294,000 | $365,000 | $2,592,000 | $2,371,000 |
| Total Equity Gross Minority Interest | $-294,000 | $365,000 | $2,592,000 | $2,371,000 |
| Stockholders Equity | $-294,000 | $365,000 | $2,592,000 | $2,371,000 |
| Retained Earnings | $-16,738,000 | $-14,839,000 | $-9,930,000 | $-5,196,000 |
| Other | ||||
| Ordinary Shares Number | $71,008,144 | $69,931,056 | $68,808,970 | $64,601,649 |
| Share Issued | $71,008,144 | $69,931,056 | $68,808,970 | $64,601,649 |
| Tangible Book Value | $-294,000 | $365,000 | $2,592,000 | $2,371,000 |
| Invested Capital | $-137,000 | $526,000 | $2,754,000 | $2,548,000 |
| Working Capital | $-340,000 | $375,000 | $2,395,000 | $2,487,000 |
| Capital Lease Obligations | $0 | $39,000 | $114,000 | $0 |
| Total Capitalization | $-294,000 | $526,000 | $2,592,000 | $2,548,000 |
| Additional Paid In Capital | $16,374,000 | $15,135,000 | $12,454,000 | $7,503,000 |
| Capital Stock | $70,000 | $69,000 | $68,000 | $64,000 |
| Common Stock | $70,000 | $69,000 | $68,000 | $64,000 |
| Current Deferred Revenue | $0 | $50,000 | $50,000 | $0 |
| Current Capital Lease Obligation | $0 | $39,000 | $74,000 | $0 |
| Current Accrued Expenses | $216,000 | $258,000 | $225,000 | $269,000 |
| Dueto Related Parties Current | $114,000 | $64,000 | $83,000 | $65,000 |
| Net PPE | $35,000 | $140,000 | $226,000 | $31,000 |
| Accumulated Depreciation | $-58,000 | $-37,000 | $-20,000 | $-10,000 |
| Gross PPE | $93,000 | $177,000 | $246,000 | $41,000 |
| Leases | $19,000 | $19,000 | $19,000 | $3,000 |
| Other Properties | $19,000 | $103,000 | $173,000 | - |
| Machinery Furniture Equipment | $55,000 | $55,000 | $54,000 | $38,000 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $3,000 | $11,000 | $3,000 | $3,000 |
| Long Term Capital Lease Obligation | - | $0 | $40,000 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,386,000 | $-3,234,000 | $-3,425,000 | $-2,513,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,386,000 | $-3,232,000 | $-3,375,000 | $-2,482,000 |
| Cash Flow From Continuing Operating Activities | $-1,386,000 | $-3,232,000 | $-3,375,000 | $-2,482,000 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-2,000 | $-59,000 | $-61,000 |
| Cash Flow From Continuing Investing Activities | $0 | $-2,000 | $-59,000 | $-61,000 |
| Capital Expenditure | - | $-2,000 | $-50,000 | $-31,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $755,000 | $1,000,000 | $3,625,000 | $3,491,000 |
| Financing Cash Flow | $750,000 | $1,000,000 | $3,625,000 | $3,491,000 |
| Cash Flow From Continuing Financing Activities | $750,000 | $1,000,000 | $3,625,000 | $3,491,000 |
| Net Common Stock Issuance | $755,000 | $1,000,000 | $3,625,000 | $3,491,000 |
| Common Stock Issuance | $755,000 | $1,000,000 | $3,625,000 | $3,491,000 |
| Other | ||||
| Repayment Of Debt | $-5,000 | $0 | - | - |
| End Cash Position | $129,000 | $767,000 | $3,002,000 | $2,815,000 |
| Beginning Cash Position | $767,000 | $3,002,000 | $2,815,000 | $1,866,000 |
| Effect Of Exchange Rate Changes | $-2,000 | $-1,000 | $-4,000 | $1,000 |
| Changes In Cash | $-636,000 | $-2,234,000 | $191,000 | $948,000 |
| Net Issuance Payments Of Debt | $-5,000 | $0 | - | - |
| Net Long Term Debt Issuance | $-5,000 | $0 | - | - |
| Long Term Debt Payments | $-5,000 | $0 | - | - |
| Net PPE Purchase And Sale | $0 | $-2,000 | $-50,000 | $-31,000 |
| Purchase Of PPE | $0 | $-2,000 | $-50,000 | $-31,000 |
| Change In Working Capital | $5,000 | $-19,000 | $47,000 | $-121,000 |
| Change In Payables And Accrued Expense | $-1,000 | $6,000 | $35,000 | $-83,000 |
| Change In Payable | $-1,000 | $6,000 | $35,000 | $-83,000 |
| Change In Receivables | $6,000 | $-25,000 | $12,000 | $-38,000 |
| Changes In Account Receivables | $6,000 | $-25,000 | $12,000 | $-38,000 |
| Other Non Cash Items | $2,000 | $-3,000 | $-28,000 | $11,000 |
| Stock Based Compensation | $485,000 | $1,682,000 | $1,330,000 | $1,339,000 |
| Depreciation Amortization Depletion | $21,000 | $17,000 | $10,000 | $5,000 |
| Depreciation And Amortization | $21,000 | $17,000 | $10,000 | $5,000 |
| Depreciation | $21,000 | $17,000 | $10,000 | $5,000 |
| Net Income From Continuing Operations | $-1,899,000 | $-4,909,000 | $-4,734,000 | $-3,716,000 |
| Net Investment Purchase And Sale | - | $0 | $-9,000 | $-30,000 |
| Purchase Of Investment | - | $0 | $-9,000 | $-30,000 |
Fetched: 2026-02-02